Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases.
APOBECs
CRISPRa
cytidine deaminases
deamination
foreign DNA
innate immunity
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Sep 2020
18 Sep 2020
Historique:
received:
10
08
2020
revised:
07
09
2020
accepted:
16
09
2020
entrez:
23
9
2020
pubmed:
24
9
2020
medline:
16
3
2021
Statut:
epublish
Résumé
Restriction of foreign DNA is a fundamental defense mechanism required for maintaining genomic stability and proper function of mammalian cells. APOBEC cytidine deaminases are crucial effector molecules involved in clearing pathogenic DNA of viruses and other microorganisms and improperly localized self-DNA (DNA leakages). Mastering the expression of APOBEC provides the crucial means both for developing novel therapeutic approaches for combating infectious and non-infectious diseases and for numerous research purposes. In this study, we report successful application of a CRISPRa approach to effectively and specifically overexpress APOBEC3A and APOBEC3B deaminases and describe their effects on episomal and integrated foreign DNA. This method increased target gene transcription by >6-50-fold in HEK293T cells. Furthermore, CRISPRa-mediated activation of APOBEC3A/APOBEC3B suppressed episomal but not integrated foreign DNA. Episomal GC-rich DNA was rapidly destabilized and destroyed by CRISPRa-induced APOBEC3A/APOBEC3B, while the remaining DNA templates harbored frequent deaminated nucleotides. To conclude, the CRISPRa approach could be readily utilized for manipulating innate immunity and investigating the effects of the key effector molecules on foreign nucleic acids.
Identifiants
pubmed: 32962129
pii: ijms21186865
doi: 10.3390/ijms21186865
pmc: PMC7557733
pii:
doi:
Substances chimiques
Minor Histocompatibility Antigens
0
Proteins
0
DNA
9007-49-2
p300-CBP Transcription Factors
EC 2.3.1.48
p300-CBP-associated factor
EC 2.3.1.48
APOBEC3A protein, human
EC 3.5.4.5
APOBEC3B protein, human
EC 3.5.4.5
Cytidine Deaminase
EC 3.5.4.5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Science Foundation
ID : 20-15-00373
Références
Sci Rep. 2012;2:763
pubmed: 23094138
Sci Rep. 2019 Feb 28;9(1):3109
pubmed: 30816165
Mol Biol (Mosk). 2019 Mar-Apr;53(2):311-323
pubmed: 31099781
Microorganisms. 2019 Nov 06;7(11):
pubmed: 31698767
Mol Ther. 2016 Mar;24(3):499-507
pubmed: 26607397
Cell Host Microbe. 2011 May 19;9(5):363-75
pubmed: 21575908
Blood. 2009 Aug 27;114(9):1864-74
pubmed: 19556424
J Infect Dis. 2019 Jul 19;220(4):567-577
pubmed: 30923817
Sci Rep. 2019 Feb 28;9(1):3134
pubmed: 30816279
J Virol. 2018 Apr 27;92(10):
pubmed: 29491156
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Curr Opin Microbiol. 2015 Aug;26:1-9
pubmed: 25795286
Nat Genet. 2013 Sep;45(9):970-6
pubmed: 23852170
J Virol. 2011 Aug;85(15):7594-602
pubmed: 21632763
PLoS One. 2015 Mar 26;10(3):e0121608
pubmed: 25811715
Viruses. 2019 Oct 31;11(11):
pubmed: 31683589
Nat Biotechnol. 2015 May;33(5):510-7
pubmed: 25849900
Science. 2014 Mar 14;343(6176):1221-8
pubmed: 24557838
Nat Methods. 2016 Jul;13(7):563-567
pubmed: 27214048
Trends Genet. 2016 Jan;32(1):16-28
pubmed: 26608778
Science. 2015 Mar 13;347(6227):aaa2630
pubmed: 25636800
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Immunity. 2013 May 23;38(5):870-80
pubmed: 23706668
Cell. 2006 Feb 24;124(4):767-82
pubmed: 16497587
Viral Immunol. 2014 May;27(4):140-50
pubmed: 24801776
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
Science. 2019 Aug 16;365(6454):
pubmed: 31320558
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Int J Mol Sci. 2019 Nov 30;20(23):
pubmed: 31801211
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Cell. 2013 Jul 18;154(2):442-51
pubmed: 23849981
Nat Struct Mol Biol. 2010 Feb;17(2):222-9
pubmed: 20062055
J Virol. 2015 Jan;89(1):688-702
pubmed: 25355878
Cancer Res. 2015 Nov 1;75(21):4538-47
pubmed: 26420215
Immunology. 2010 Sep;131(1):40-9
pubmed: 20636339
Mol Cancer Res. 2017 Jun;15(6):735-743
pubmed: 28232385
Nat Rev Microbiol. 2016 Jun;14(6):360-73
pubmed: 27174148
Virology. 2015 May;479-480:131-45
pubmed: 25818029
J Hepatol. 2018 Dec;69(6):1231-1241
pubmed: 30142426
Mol Ther. 2016 Mar;24(3):508-21
pubmed: 26775808
Sci Rep. 2019 Feb 12;9(1):1847
pubmed: 30755668
Genes (Basel). 2018 Oct 05;9(10):
pubmed: 30301171
Genomics. 2002 Mar;79(3):285-96
pubmed: 11863358
Nucleic Acids Res. 2007;35(21):7096-108
pubmed: 17942420
Nature. 2003 Jul 3;424(6944):99-103
pubmed: 12808466
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7249-56
pubmed: 26668372
J Immunol. 2015 May 15;194(10):4914-23
pubmed: 25855353
J Biol Chem. 2012 Aug 31;287(36):30812-22
pubmed: 22822074
Nat Rev Immunol. 2008 Dec;8(12):911-22
pubmed: 18989317
Gastroenterology. 2016 Jan;150(1):194-205
pubmed: 26416327